• LAST PRICE
    2.0750
  • TODAY'S CHANGE (%)
    Trending Down-0.0350 (-1.6588%)
  • Bid / Lots
    2.0700/ 15
  • Ask / Lots
    2.0800/ 23
  • Open / Previous Close
    2.1100 / 2.1100
  • Day Range
    Low 2.0550
    High 2.1100
  • 52 Week Range
    Low 1.7900
    High 31.0100
  • Volume
    153,158
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.11
TimeVolumeVTYX
09:32 ET34412.1
09:34 ET56362.08
09:36 ET2002.08
09:38 ET8642.089
09:39 ET1002.08
09:41 ET34392.08
09:43 ET82902.09
09:45 ET37862.078
09:48 ET10002.075
09:50 ET15032.075
09:52 ET59592.08
09:54 ET32332.075
09:56 ET8582.075
09:57 ET22222.085
09:59 ET1002.0899
10:01 ET33002.0764
10:03 ET2002.075
10:06 ET59412.0793
10:08 ET8962.08
10:10 ET13892.075
10:12 ET22002.075
10:14 ET38972.08
10:15 ET28732.075
10:17 ET48002.075
10:19 ET18202.0799
10:21 ET8002.075
10:24 ET92512.065
10:26 ET102672.0601
10:28 ET1002.07
10:30 ET3002.065
10:32 ET189682.07
10:33 ET20962.075
10:35 ET5002.075
10:37 ET17952.0792
10:39 ET25822.065
10:42 ET12002.065
10:44 ET56232.06
10:46 ET7002.065
10:48 ET15002.065
10:50 ET2002.065
10:51 ET36472.06
10:53 ET11002.0658
10:55 ET7002.065
10:57 ET32972.075
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTYX
Ventyx Biosciences Inc
149.1M
-0.7x
---
United StatesABOS
Acumen Pharmaceuticals Inc
150.2M
-2.2x
---
United StatesPDSB
PDS Biotechnology Corp
151.3M
-3.4x
---
United StatesIMUX
Immunic Inc
143.2M
-1.1x
---
United StatesCNTX
Context Therapeutics Inc
141.7M
-1.8x
---
United StatesINO
Inovio Pharmaceuticals Inc
147.0M
-1.1x
---
As of 2024-10-03

Company Information

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.

Contact Information

Headquarters
12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
Phone
858-945-2393
Fax
302-655-5049

Executives

Executive Chairperson of the Board
Sheila Gujrathi
President, Chief Executive Officer, Founder, Director
Raju Mohan
Interim Principal Financial Officer, Interim Principal Accounting Officer
Roy Gonzales
Chief Operating Officer
Matthew Moore
Chief Scientific Officer
John Nuss

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$149.1M
Revenue (TTM)
$0.00
Shares Outstanding
70.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.79
Book Value
$4.12
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.